Engraftment, neuroglial transdifferentiation and behavioral recovery after complete spinal cord transection in rats

Assunção-Silva, 2015, Stem Cells Int, Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration, 948040

Baptiste, 2007, Prog Brain Res, Update on the treatment of spinal cord injury, 217

Basso, 1995, J Neurotrauma, A sensitive and reliable locomotor rating scale for open field testing in rats, 1

Benson, 2005, Proc Natl Acad Sci U S A, Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth, 10694

Canavero, 2016, CNS Neurosci Ther, The Spark of Life: Engaging the Cortico-Truncoreticulo-Propriospinal Pathway by Electrical Stimulation, 260

Canavero, 2016, Surg Neurol Int, Houston, GEMINI has landed: Spinal cord fusion achieved, S626

Canavero, 2016, Surgery, Neurologic foundations of spinal cord fusion (GEMINI), 11

Cao, 2009, Chin Med J (Engl), Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury, 225

Caplan, 2007, J Cell Physiol, Adult mesenchymal stem cells for tissue engineering versus regenerative medicine, 341

Chen, 2000, Nature, Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1, 434

Coleman, 2000, J Spinal Disord, A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury, 185

Czernik, 2013, J Cell Biochem, Differentiation potential and GFP labeling of sheep bone marrow-derived mesenchymal stem cells, 134

Das, 2011, Curr Stem Cell Res Ther, Current status and prospective application of stem cell-based therapies for spinal cord injury, 93

Desantis, 2015, Ann Anat, Ultrastructural study of cultured ovine bone marrow-derived mesenchymal stromal cells, 43

Dezawa, 2004, J Clin Invest, Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation, 1701

Dominici, 2006, Cytotherapy, Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement, 315

Eftekharpour, 2008, Neurosurg Focus, Current status of experimental cell replacement approaches to spinal cord injury, E19

Faden, 1982, Neurology, Comparison of early and late naloxone treatment in experimental spinal injury, 677

Friedenstein, 1970, Cell Tissue Kinet, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, 393

Goldschlager, 2013, Curr Stem Cell Res Ther, Current and future applications for stem cell therapies in spine surgery, 381

Hall, 1995, J Neurotrauma, Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord, 245

Hall, 2004, NeuroRx, Neuroprotection and acute spinal cord injury: A reappraisal, 80

Harrop, 2012, J Neurosurg Spine, Evaluation of clinical experience using cell-based therapies in patients with spinal cord injury: A systematic review, 230

Hata, 2006, J Cell Biol, RGMa inhibition promotes axonal growth and recovery after spinal cord injury, 47

Holden, 2002, Science, Stem cells.Plasticity: Time for a reappraisal?, 2126

Hurlbert, 2000, J Neurosurg, Methylprednisolone for acute spinal cord injury: An inappropriate standard of care, 1

Ito Y, Sugimoto Y, Tomioka M, Kai N, Tanaka M. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: A prospective study about neurological recovery and early complications. Spine (Phila. Pa. 1976) 2009;34:2121-4.

Jiang, 2002, Nature, Pluripotency of mesenchymal stem cells derived from adult marrow, 41

Joyce, 2010, Regen Med, Mesenchymal stem cells for the treatment of neurodegenerative disease, 933

Karimi-Abdolrezaee, 2012, Adv Exp Med Biol, Stem cells and spinal cord injury repair, 53

Koda, 2005, Neuroreport, Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice, 1763

Koshizuka, 2004, J Neuropathol Exp Neurol, Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice, 64

Louro, 2008, Neurol Res, Stem and progenitor cell therapies: Recent progress for spinal cord injury repair, 5

Löw, 2008, J Neurosci, Netrin-1 is a novel myelin-associated inhibitor to axon growth, 1099

Lyahyai, 2012, BMC Vet Res, Isolation and characterization of ovine mesenchymal stem cells derived from peripheral blood, 169

Makino, 1999, J Clin Invest, Cardiomyocytes can be generated from marrow stromal cells in vitro, 697

Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila. Pa. 1976) 2001;26:426-30.

McCreedy, 2012, Neurosci Lett, Combination therapies in the CNS: Engineering the environment, 115

McKerracher, 1994, Neuron, Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth, 805

Meirelles, 2009, Front Biosci, Methodology, biology and clinical applications of mesenchymal stem cells, 4281

Miller, 2012, Neurosci Lett, Translating stem cell therapies to the clinic, 87

Moreau-Fauvarque, 2003, J Neurosci, The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion, 9229

Mukhopadhyay, 1994, Neuron, A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration, 757

Nandoe, 2009, J Spinal Cord Med, Stem cell-based therapies for spinal cord injury, 105

Noble, 2011, Curr Opin Neurol, Cell therapies for the central nervous system: How do we identify the best candidates?, 570

Obermair, 2008, Physiology (Bethesda), Endogenous neural progenitor cells as therapeutic target after spinal cord injury, 296

Phinney, 2007, Stem Cells, Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair--current views, 2896

Prockop, 1997, Science, Marrow stromal cells as stem cells for nonhematopoietic tissues, 71

Reynolds, 1992, Science, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, 1707

Richardson, 1980, Nature, Axons from CNS neurons regenerate into PNS grafts, 264

Rowland, 2008, Neurosurg Focus, Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon, E2

Ruff, 2012, Exp Neurol, Cell-based transplantation strategies to promote plasticity following spinal cord injury, 78

Ryan, 2007, Clin Exp Immunol, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, 353

Sakaguchi, 2005, Arthritis Rheum, Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source, 2521

Sakiyama-Elbert, 2001, FASEB J, Development of growth factor fusion proteins for cell-triggered drug delivery, 1300

Sanchez-Ramos, 2000, Exp Neurol, Adult bone marrow stromal cells differentiate into neural cells in vitro, 247

Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila. Pa. 1976) 2001;26:S2-12.

Short, 2000, Spinal Cord, High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective, 273

Silva, 2014, Prog Neurobiol, From basics to clinical: A comprehensive review on spinal cord injury, 25

Silver, 2004, Nat Rev Neurosci, Regeneration beyond the glial scar, 146

Simard, 2004, FASEB J, Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia, 998

Stenderup, 2003, Bone, Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells, 919

Stocum, 2002, J Musculoskelet Neuronal Interact, Regenerative biology and medicine, 270

Takayama, 2009, Anat Rec (Hoboken), Characteristic morphology and distribution of bone marrow derived cells in the cornea, 756

Vawda, 2013, Curr Stem Cell Res Ther, Mesenchymal cells in the treatment of spinal cord injury: Current and future perspectives, 25

Wang, 2002, Nature, Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth, 941

Weiss, 1996, J Neurosci, Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis, 7599

Wyatt, 2012, Prog Brain Res, Stem cell-based treatments for spinal cord injury, 233

Zuk, 2002, Mol Biol Cell, Human adipose tissue is a source of multipotent stem cells, 4279